News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,628 Results
Type
Article (14421)
Company Profile (281)
Press Release (254926)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79783)
Career Advice (168)
Deals (13261)
Drug Delivery (37)
Drug Development (50538)
Employer Resources (32)
FDA (5732)
Job Trends (5188)
News (144876)
Policy (10123)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (926)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21738)
ALS (63)
Alzheimer's disease (850)
Antibody-drug conjugate (ADC) (98)
Approvals (5758)
Artificial intelligence (126)
Autoimmune disease (18)
Automation (5)
Bankruptcy (106)
Best Places to Work (4611)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (51)
Brain cancer (20)
Breast cancer (155)
Cancer (1437)
Cardiovascular disease (117)
Career advice (148)
Career pathing (2)
CAR-T (113)
Cell therapy (318)
Cervical cancer (8)
Clinical research (41085)
Collaboration (536)
Compensation (256)
Complete response letters (13)
COVID-19 (1044)
CRISPR (39)
C-suite (158)
Cystic fibrosis (76)
Data (1466)
Denatured (11)
Depression (30)
Diabetes (134)
Diagnostics (1324)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (85)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (29812)
Editorial (18)
Employer branding (4)
Employer resources (30)
Events (49146)
Executive appointments (450)
FDA (6417)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (499)
Gene editing (93)
Generative AI (12)
Gene therapy (243)
GLP-1 (368)
Government (1108)
Grass and pollen (2)
Guidances (20)
Healthcare (6720)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (90)
Indications (20)
Infectious disease (1113)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (64)
Interviews (19)
IPO (7283)
IRA (11)
Job creations (867)
Job search strategy (137)
Kidney cancer (7)
Labor market (5)
Layoffs (207)
Leadership (3)
Legal (1412)
Liver cancer (32)
Lung cancer (202)
Lymphoma (97)
Machine learning (4)
Management (7)
Manufacturing (137)
MASH (53)
Medical device (2630)
Medtech (2631)
Mergers & acquisitions (6302)
Metabolic disorders (385)
Multiple sclerosis (52)
NASH (14)
Neurodegenerative disease (65)
Neuropsychiatric disorders (25)
Neuroscience (1249)
NextGen: Class of 2025 (2070)
Non-profit (943)
Northern California (1667)
Now hiring (22)
Obesity (192)
Opinion (103)
Ovarian cancer (61)
Pain (43)
Pancreatic cancer (54)
Parkinson's disease (119)
Partnered (8)
Patents (125)
Patient recruitment (73)
Peanut (35)
People (25708)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14508)
Phase II (19111)
Phase III (12086)
Pipeline (786)
Policy (44)
Postmarket research (856)
Preclinical (6102)
Press Release (30)
Prostate cancer (59)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (288)
Real estate (1425)
Recruiting (12)
Regulatory (8658)
Reports (15)
Research institute (947)
Resumes & cover letters (21)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (58)
Series A (98)
Series B (62)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1460)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (12)
Startups (1976)
State (1)
Stomach cancer (5)
Supply chain (22)
Tariffs (6)
The Weekly (37)
United States (13002)
Vaccines (213)
Venture capitalists (34)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (35)
Last 7 days (369)
Last 30 days (1376)
Last 365 days (19574)
2025 (5877)
2024 (20651)
2023 (22530)
2022 (26962)
2021 (27951)
2020 (23543)
2019 (16486)
2018 (11953)
2017 (13809)
2016 (11958)
2015 (14430)
2014 (10463)
2013 (7547)
2012 (7601)
2011 (7688)
2010 (7472)
Location
Africa (154)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17380)
Australia (2952)
California (3780)
Canada (1125)
China (345)
Colorado (146)
Connecticut (149)
Delaware (97)
Europe (37404)
Florida (458)
Georgia (115)
Idaho (16)
Illinois (230)
India (10)
Indiana (95)
Iowa (2)
Japan (74)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (477)
Massachusetts (2993)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (949)
New Mexico (12)
New York (1020)
North Carolina (547)
North Dakota (4)
Northern California (1667)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (717)
Puerto Rico (5)
Rhode Island (18)
South America (212)
South Carolina (4)
Southern California (1460)
Tennessee (25)
Texas (440)
Utah (54)
Virginia (77)
Washington D.C. (30)
Washington State (345)
Wisconsin (14)
269,628 Results for "spotlight therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Deep Dive: Cardiovascular Disease Back in the Spotlight
In this deep dive,
BioSpace
explores the diverse therapeutic modalities now in development, as well as the opportunities and battles for market dominance in this emerging space.
March 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation
April 23, 2025
·
2 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Press Releases
PROCEPT BioRobotics’ Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 25, 2025
·
6 min read
Press Releases
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
February 26, 2025
·
9 min read
Press Releases
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
December 12, 2024
·
10 min read
Press Releases
Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B
November 14, 2024
·
3 min read
Press Releases
Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
October 14, 2024
·
11 min read
Drug Development
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
Jasper Therapeutics, Inc. today announced that the first patient has been dosed in Jasper’s Phase 1b/2a (SPOTLIGHT) clinical study of subcutaneous briquilimab for the treatment of CIndU.
March 19, 2024
·
6 min read
Press Releases
Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
September 30, 2024
·
12 min read
1 of 26,963
Next
